Results 61 to 70 of about 101,595 (233)

Medicamentos huérfanos

open access: yesArbor, 2018
Los medicamentos huérfanos son aquellos fármacos destinados al tratamiento de enfermedades de baja prevalencia, también conocidas como enfermedades raras. La investigación y desarrollo de nuevas terapias para este conjunto heterogéneo de enfermedades presenta una serie de dificultades que están bien reconocidas.
Juan Manuel Fontanet Sacristán   +1 more
openaire   +3 more sources

Avaliação do serviço de dispensação de medicamentos na rede de atenção básica do SUS [PDF]

open access: yes, 2012
Dissertação (mestrado) - Universidade Federal de Santa Catarina, Centro de Ciências da Saúde, Programa de Pós-Graduação em Saúde Coletiva, Florianópolis, 2010Os medicamentos assumem um papel importante nos serviços de saúde pública, constituindo-se no ...
Sartor, Vanessa de Bona
core  

Validation of the Spanish Version of the Wound‐QoL‐14 Wound‐Specific Health‐Related Quality of Life Questionnaire

open access: yesInternational Wound Journal, Volume 23, Issue 6, June 2026.
ABSTRACT The aim was to validate the Spanish/Spain version of the Wound‐QoL‐14. Clinical data were prospectively collected from participants who completed the questionnaire at baseline and at a follow‐up visit. COSMIN guidelines were followed to evaluate feasibility, reliability, construct validity and responsiveness.
Celia Horcajada‐Reales   +3 more
wiley   +1 more source

Bol CIM 259: Microbioma y relación con medicamentos

open access: yes, 2022
Fil: Centro de Información de Medicamentos (CIM). Universidad Nacional de Rosario. Facultad de Ciencias Bioquímicas y Farmacéuticas.
Centro de Información de Medicamentos - FCByF - UNR
core  

Low‐intervention clinical trials in Spain: Do they progress?

open access: yesBritish Journal of Clinical Pharmacology, Volume 92, Issue 5, Page 1438-1444, May 2026.
Abstract Aims Low‐Intervention Clinical Trials (LICTs) are generally pragmatic trials that investigate medicinal products already authorized for use. In 2014, simplified regulatory frameworks were introduced for LICTs with the aim of reducing regulatory burden and operational complexity, to foster non‐commercial clinical trials (NCCTs); the mandatory ...
Claudia Erika Delgado‐Espinoza   +4 more
wiley   +1 more source

Quitosana y sus sales: producción nacional, caracterización y aplicaciones farmacéuticas

open access: yesAnales de la Academia de Ciencias de Cuba, 2021
Introducción: Los exoesqueletos de crustáceos constituyen fuentes de obtención de biopolímeros de gran versatilidad, y desechos sólidos que contaminan el medio ambiente. Objetivos: establecer procesos tecnológicos a escala industrial para la obtención de
Nilia de la Paz Martín-Viaña   +8 more
doaj  

Potential Effects of Prepubertal Exposure to Perfluorooctane Sulfonic Acid on the First Wave of Folliculogenesis in Young CD‐1 Mice

open access: yesBirth Defects Research, Volume 118, Issue 5, May 2026.
ABSTRACT Background Perfluorooctane sulfonic acid (PFOS) belongs to a group of synthetic chemicals referred to as per‐ and polyfluoroalkyl substances (PFAS) that are known to degrade slowly. Exposure to PFOS has been reported to cause birth defects and disrupt female sex hormone levels in mice.
Bounleut Phanavanh   +7 more
wiley   +1 more source

A pessoa idosa controlando sua situação de saúde/doença com o uso de medicamentos [PDF]

open access: yes, 2015
Tese (doutorado) - Universidade Federal de Santa Catarina, Centro de Ciências da Saúde, Programa de Pós-Graduação em Enfermagem, Florianópolis, 2015O presente estudo teve como objetivos compreender o uso de medicamentos pelo idoso residente em área ...
Oliveira, Luciane Paula Batista Araújo de
core  

Adaptive Machine Learning Framework for Optimizing the Affinity Purification of Adeno‐Associated Viral Vectors

open access: yesBiotechnology and Bioengineering, Volume 123, Issue 5, Page 1107-1122, May 2026.
ABSTRACT Adeno‐associated viral (AAV) vectors for gene therapy are becoming integral to modern medicine, providing therapeutic options for diseases once deemed incurable. Currently, viral vector purification is a critical bottleneck in the gene therapy industry, impacting product efficacy and safety as well as accessibility and cost to patients ...
Kelvin P. Idanwekhai   +9 more
wiley   +1 more source

Bol CIM 248: Miopatías asociadas a medicamentos

open access: yes, 2020
Fil: Centro de Información de Medicamentos (CIM). Universidad Nacional de Rosario. Facultad de Ciencias Bioquímicas y Farmacéuticas.
Centro de Información de Medicamentos - FCByF - UNR
core  

Home - About - Disclaimer - Privacy